Glaxo Slashes Funding for Doctor-Educational Programs; Is More Change Needed?
In a move seen as an effort to distance itself from the ongoing controversy over drug company financial support of medical research, GlaxoSmithKline PLC said today it plans to reduce the amount of money it pays to support physician education programs.
Continue →Lingering Questions About Cell Phone Cancer Risks Prompt Congressional Inquiry
Saying questions about whether cell phones cause cancer are just like the cloud of suspicion that surrounded cigarettes for decades before tobacco use was definitively linked to cancers, a Congressional leader is vowing to thoroughly investigate the possible link between cell phone use and cancer.
Continue →U.S. Healthcare Overhaul May Mean Big Changes for Medical Malpractice Litigation
In the raging debate about healthcare reform, we’ve all heard about “death panels,” the benefits and disadvantages of a so-called public option for those who can’t afford private health insurance, and the skyrocketing costs of overhauling the ailing United States healthcare system.
Continue →FDA Offers New Way for Industry Reporting of Possible Food Poisoning Cases
Food industry officials now have a new, electronic way to alert the Food and Drug Administration about possible cases of salmonella, Listeria, E. coli, and other potentially deadly forms of food poisoning.
Continue →Big FDA Decisions Coming Soon on Two Controversial Vaccines
In the next week, an advisory panel of the Food & Drug Administration is expected to make decisions on two controversial vaccines designed to treat a commonly carried virus that is a primary cause of cervical cancer.
Continue →FDA’s Handling of Xenical and Alli Investigation Signals New Era for Embattled Agency
With yesterday’s announcement of an ongoing investigation into dozens of reports of liver failure and liver damage in users of the popular weight-loss drugs Xenical and Alli, the Food and Drug Administration sent a strong message to drug manufacturers and consumers.
Continue →FDA Proposes New Rules for Reporting of Medical Device and Drug Problems
The Food and Drug Administration is considering requiring makers of drugs, biologics, and medical devices to report problems with the products once they are available to patients to the FDA in electronic form rather than on paper.
Continue →One FDA Director Resigns, Another Reportedly Under Investigation
Big changes this week over at the Food and Drug Administration, where one high-ranking official has resigned amid concerns about approvals he authorized for questionable medical devices while another top official reportedly is under investigation for possible conflicts of interest.
Continue →Is Apple Hiding Complaints of Flaming iPods?
iPod users reportedly have been complaining to the Consumer Product Safety Commission for years about the popular MP3 players suddenly bursting into flames or getting so hot that they inflict painful burns to the skin. But iPod maker Apple is being accused of trying to keep a tight lid on the consumer reports out of fear of hurting skyrocketing sales of the blockbuster product.
Continue →Don’t Even Think About Suing if You’re Hurt by Swine Flu Vaccines
The shots won’t even be available for months, but makers of vaccines designed to guard against outbreaks of the so-called Swine Flu will be immune from personal-injury lawsuits brought on behalf of patients who are injured or killed after getting them.
Continue →
facebook
rss
twitter